Showing results (431-440 of 615) with videos related to
Sort By:
Pageof 62
Bone Marrow Transplantation|December 2, 2000
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.Bone Marrow Transplantation|January 1, 1988
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantationJ E Sanders, C D Buckner, R A Clift, et al.Experimental Hematology|March 1, 1976
Recovery from aplastic anemia following attempted marrow transplantationE D Thomas, R Storb, E R Giblett, et al.Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.The New England Journal of Medicine|September 21, 1989
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemiaR P Witherspoon, L D Fisher, G Schoch, et al.The American Journal of Pathology|June 1, 1978
Chronic cutaneous graft-versus-host disease in manH M Shulman, G E Sale, K G Lerner, et al.Bone Marrow Transplantation|September 1, 1988
Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host diseaseP J Martin, J A Hansen, B Torok-Storb, et al.Pageof 62